Nearly all patients were on pharmacological therapy for type 2 diabetes (94%): 244 were on oral hypoglycaemic therapy alone, 6 on subcutaneous insulin therapy alone and 25 on both. This evidence concerns the gene INS and type 2 diabetes mellitus.